Ventas

Q2 FY2026 EarningsQ2 FY26 results beat consensus across key metrics, with revenue of $1.73B vs. $1.69B expected and normalized EPS of $0.14 vs. $0.11 expected. Performance was primarily driven by the SHOP segment, which saw a 40.9% YoY NOI increase and 16.3% Same-Store NOI growth due to 88.7% occupancy and robust RevPOR. While NNN revenue fell 18.2% YoY due to strategic segment conversions, the outpatient OM&R portfolio remained stable with 88.5% occupancy and 3.4% Same-Store NOI growth.